Stuart Quin

Stuart Quin is a seasoned professional in the healthcare investment and diagnostics sector, currently serving as a Partner at GHO Capital Partners LLP and holding board positions with Sterling Pharma Solutions and Genesis Research Group. With a background in leadership roles, Quin has been a Non-Executive Director at AliveDx and Medica Group, and a Member of the Investment Committee at Alta Semper Capital LLP. Previous experience includes serving as Chief Executive for Bain & Company and SYNLAB UK & Ireland, as well as Regional Chief Executive at SYNLAB International. Quin holds an MBA from INSEAD and a PhD in Immunology from Imperial College London, complemented by earlier studies at the University of Edinburgh.